Pharmaceuticals News
|
The technology and approach of virtual reality aims to create a virtual world parallel to reality that is both immersive and interactive. How can this aid pharmaceuticals?
|
|
The pharmaceutical sector has become one of the top targets for rogue actors in terms of seeking to exploit digital vulnerabilities. This means that continually assessing the cybersecurity policy and having a back-up plan is of great importance.
|
|
How can new pharmaceuticals be delivered to market faster and what advantages can be gained from technological improvements to drug delivery? A leading professional offers his expertise.
|
|
The pharmaceuticals and healthcare sectors are making effective use of digital technology, such as augmented reality. Digital Journal presents three examples of the application, in each case helping to improve patient outcomes.
|
|
Digital twins refers creating a virtual and connected model of a process, product, or service. Pharmaceutical manufacturers are making use of digital twins to drive process improvements through the manufacturing plant.
|
|
For an industry based largely on manufacturing and scientific research, the pharmaceutical sector has needed to adapt in novel ways in order to meet the home working requirements fostered upon it due to the COVID-19 pandemic.
|
|
KPMG, IBM, Merck and Walmart published the results from an FDA pilot program conducted to evaluate the use of blockchain to track and trace prescription drugs. The pilot was reported to be successful.
|
|
U.S. pharma giant ExecuPharm has confirmed that it was hit by a ransomware attack on March 13. The company stated that key data inked to individuals could be compromised.
|
|
Over the course of just five years, the global market in biosimilar medicines has risen to over $5 billion. Biosimilars are complex drugs identical to a branded one, but manufactured by a different company.
|
|
Continuous manufacturing forms part of the industry 4.0 paradigm, and following success in other sectors this approach is being applied to pharmaceuticals (moving from "batch manufacturing" to "continuous manufacturing").
|
|
Today’s clinical trial and research space faces a number of challenges, including limitations in data quality and trials that effectively address underserved populations, impacting the efficacy of drug benefits and treatments of complex diseases.
|
|
Nottingham -
The importance of a contamination control strategy and a science-based approach to addressing microbial issues are the key elements for any pharmaceutical microbiologist’s toolbox. These were the main lessons from the Pharmig annual conference.
|
|
By AFP
Paris -
Residues from billions of doses of antibiotics, painkillers and antidepressants pose a significant risk to freshwater ecosystems and the global food chain, a new analysis said Thursday.
|
|
Nottingham -
Each November pharmaceutical microbiologists converge for the annual Pharmig conference to discuss medicinal safety and the latest developments in all-things microbiology. On day one of year's event pharmaceutical regulators outlined their expectations.
|
|
The company TraceLink has launched its Digital Network Platform. The aim is to develop new supply chain operating models based on the patient, and with driving network members to work together for better traceability and standards.
|
|
Pharmaceuticals remains in a state of change, from precision medicines to artificial intelligence; and with further restructuring and mergers, and new job roles. These trends are drawn out in a new industry survey.
|
|
A consortium of industry, academia and government have developed a new approach to digital design for pharmaceutical product and process development. Called ADDoPT, the focus is on process understanding and predictive modeling.
|
|
Researchers based at the University of Wisconsin - Madison have developed at method to synthesize acetaminophen — the active ingredient in Tylenol — from a natural compound derived from plant material, reducing the reliance upon fossil fuels.
|
|
A sweeping study into global health procurement finds that some low-income countries are paying over twenty times more for generic drug products. Lifesaving medicines continue to remain out of reach for many of those who need them the most.
|
|
The Government of British Columbia has announced a program in which patients taking originator biologic drugs will be "switched" or transitioned by their clinicians to a biosimilar biologic drug within a six-month period.
|
|
Dublin -
Water may seem like a routine part of the production of medicines but water contaminated with microorganisms is a cause of drug product recalls and can lead to patient harm. The importance of water quality was the theme of a recent conference.
|
|
New legislation requiring pharmaceutical companies to implement 'serialization' is coming into force. This means that no counterfeit product should enter the supply chain and no legitimate product is diverted from its intended destination.
|
|
The digital transformation of pharmaceutical manufacturing is continuing at a rapid pace as companies attempt to mine the sources of data available. Innovations include predictive analytics, big data analytics, and creating the digital plant.
|
|
Bethesda -
FDA’s Pilot Program under the Drug Supply Chain Security Act (DSCSA) requires the Agency to explore and evaluate methods to enhance the safety and security of the pharmaceutical distribution supply chain. This includes blockchain.
|
|
In the U.S., drug companies spend more than $50 billion on R&D, while in Europe spending surpasses €30 billion. To help lower costs and to reduce the time taken for new drugs to hit the market, the pharmaceutical sector is turning to machine learning.
|
|
Birmingham -
Microbiologist met recently in the U.K. to discuss best practices for monitoring cleanroom environments (the space within which pharmaceutical medicines are produced). The theme of the event was on risk-assessment.
|
|
The medical and pharmaceutical sectors are facing disruption from companies that occupy space traditionally outside of healthcare. These are companies like Apple and Google, plus an array of startups. What does this mean for the healthcare landscape?
|
|
A number of pharmaceutical companies are embracing connected technology with a bid to improve efficiencies and to reduce costs. This digital transformation of the sector includes smart factories and connected plants.
|
|
Ginkgo Bioworks, a startup known for its work turning bacteria into consumer goods, is partnering with marijuana producer Cronos to make lab-grown cannabis.
|
|
Salt Lake City -
On Thursday, seven health care systems and three philanthropic groups announced the formation of their own generic drug company, Civica Rx, to tackle chronic shortages and high prices.
|
apis-425961 apis-422627 apis-419758 apis-419881 apis-419869 apis-418825 apis-417764 apis-417445 apis-413040 apis-411667 apis-408102 apis-407756 apis-407744 apis-407670 apis-405008 apis-404021 apis-399579 apis-398862 apis-398571 apis-396080 apis-395295 apis-392207 apis-392198 apis-390515 apis-389133 apis-388258 apis-378939 apis-377176 apis-375741 apis-375729
Pharmaceuticals Image
President Trump, along with Health and Human Services Secretary Alex Azar, announce proposed plan to reduce Medicare drug costs on Thursday. Department of Health and Human Services
Operator processing vials at a pharmaceutical facility.
Medicine vials on display at making Pharmaceuticals 2015.
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug Alexion Pharmaceuticals
Sativex contains marijuana-derived ingredients. Associated Press
Eli Lilly's global headquarters, Indianapolis, Indiana Guanaco152003
Pharmaceutical manufacturing at BPL, Elstree, UK.
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Biogen
|
|
